Low dose hormone therapy in reproductive endocrinology in China
Ge, Q.; Xiao, B.; Wu, Y.; Li, X.
Chinese Medical Journal 116(9): 1418-1420
2003
ISSN/ISBN: 0366-6999 PMID: 14527379 Document Number: 260579
Document emailed within 1 workday
Related Documents
Zhang, L.Z. 1994: Development of female reproductive endocrinology in China Chinese Medical Journal 107(3): 163-166Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Matsushima, T.; Akira, S.; Asakura, H.; Takeshita, T. 2017: Low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use Clinical and Experimental Obstetrics and Gynecology 44(1): 143-145
Saie, D.J.; Sills, E.S. 2005: Hyperprolactinemia presenting with encephalomalacia-associated seizure disorder and infertility: a novel application for bromocriptine therapy in reproductive endocrinology Neuro Endocrinology Letters 26(5): 533-535
Omurtag, K.; Grindler, N.M.; Roehl, K.A.; Bates, G.Wright.; Beltsos, A.N.; Odem, R.R.; Jungheim, E.S. 2012: How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges Fertility and sterility 97(5): 1095
Kalvachová, B.; Dvorádková, M.; Lisá, L. 2007: Growth hormone treatment in the Institute of Endocrinology Casopis Lekaru Ceskych 146(3): 205-209
Gumenetskaya, Y.V.; Mardynsky, Y.S.; Karyakin, O.B.; Gulidov, I.A.; Biryukov, V.A. 2015: An experience with dose-escalated conformal radiation therapy in hormone-radiotherapy for prostate cancer Voprosy Onkologii 61(1): 57-61
Kaba, H.; Seto, K. 1991: An olfactory memory of significance for reproductive endocrinology Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 53(5): 151-168
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925
Das, K.K.; Bhattacherjee, D.K.; Das, K.; Das Mal, A. 1995: Place of transvaginal sonography in the evaluation of reproductive endocrinology Journal of the Indian Medical Association 93(9): 349-350; 357
de Ziegler, D.; Vulliemoz, N.; Feki, A.; Lbecheole, V.; Ventura, P. 2006: Reproductive endocrinology and infertility in the light of 20 years of IVF experience Revue Medicale Suisse 2(53): 438
Pennington, G. W. 1979: Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management Journal of Clinical Pathology 32(4): 413-414
Neumann, F. 1974: Significance of comparative physiology of reproduction, endocrinology and anatomy in hormone research Berliner und Munchener Tierarztliche Wochenschrift 87(16): 308-312
van Houten, M.E.; Gooren, L.J. 2000: Differences in reproductive endocrinology between Asian men and Caucasian men--a literature review Asian Journal of Andrology 2(1): 13-20
Motta-Mena, N.V.; Puts, D.A. 2017: Endocrinology of human female sexuality, mating, and reproductive behavior Hormones and Behavior 91: 19-35
Akira, S.; Iwasaki, N.; Ichikawa, M.; Mine, K.; Kuwabara, Y.; Takeshita, T.; Tajima, H. 2009: Successful long-term management of adenomyosis associated with deep thrombosis by low-dose gonadotropin-releasing hormone agonist therapy Clinical and Experimental Obstetrics and Gynecology 36(2): 123-125
Distiller, L.A.; Sagel, J.; Polakow, E.S.; Morley, J.E. 1975: A therapeutic response to a single diagnostic dose of luteinising hormone-releasing hormone South African Medical Journal 49(2): 50-52
Kubota, O.; Onuki, Y.; Uchiyama, T.; Oishi, K.; Takeda, M. 2012: Efficacy of high-dose toremifene as a second-line hormone therapy in patients with advanced or metastatic breast cancer resistant to aromatase inhibitor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 753-757
Nomura, Y.; Tashiro, H.; Hisamatsu, K.; Toi, M. 1988: Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 513-518